# US 2024/0389924 A1 · Neuroscience and conflict resolution

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0389924 A1
- Document ID: US20240389924A1
- Status: Published application
- Kind: A1
- Application number: 18/797,623
- Filed: 2024-08-08
- Published: 2024-11-28
- Earliest claimed: 2024-08-08
- Inventors: Joel Steven Goldberg
- Web page: https://patentgrep.com/patent/US20240389924A1

## CPC

- A61B 5/4064: {Evaluating the brain (for intracranial pressure A61B5/031; for cerebral blood gases A61B5/14553; using EEG A61B5/369)}
- A61B 5/055: involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
- A61B 5/0042: {for the brain}
- A61B 5/14542: {for measuring blood gases (A61B5/14551 takes precedence)}
- A61B 5/14555: {specially adapted for the eye fundus}
- A61B 5/16: Devices for psychotechnics (using teaching or educational appliances G09B1/00 - G09B7/00); Testing reaction times {; Devices for evaluating the psychological state}
- A61B 5/165: {Evaluating the state of mind, e.g. depression, anxiety}
- A61B 5/167: {Personality evaluation}
- A61B 5/168: {Evaluating attention deficit, hyperactivity}
- A61B 5/4076: {Diagnosing or monitoring particular conditions of the nervous system}
- A61B 5/4082: {Diagnosing or monitoring movement diseases, e.g. Parkinson, Huntington or Tourette}
- A61B 5/4088: {Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia}
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 5/4845: {Toxicology, e.g. by detection of alcohol, drug or toxic products (A61B5/4848 takes precedence)}
- A61B 5/4848: {Monitoring or testing the effects of treatment, e.g. of medication}
- G01N 24/08: by using nuclear magnetic resonance (G01N24/12 takes precedence)
- G01R 33/4625: {Processing of acquired signals, e.g. elimination of phase errors, baseline fitting, chemometric analysis}
- G01R 33/465: applied to biological material, e.g. in vitro testing
- G01R 33/485: based on chemical shift information {[CSI] or spectroscopic imaging, e.g. to acquire the spatial distributions of metabolites}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G01R: MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES (indicating correct tuning of resonant circuits H03J3/12)

## Abstract

This invention is a method to predict the motor response of presumptive negotiators after simulated decision challenges through measurement of glutamate/GABA ratios in spectral MRI (MRS) of the negotiators. The sampled voxels of MRS include precentral gyrus speech (larynx) and writing (hand) areas and/or supplementary motor cortex. The glutamate/GABA ratio or excitation/inhibition (E/I) ratio is predicted to be U shaped where an elevated E/I ratio is predicted to be impulsive decision-making and lower E/I ratio is predicted to be indecisiveness. This method may aid in the screening of negotiators who may be best suited for resolution of impasse conflicts.

## Claims

### Claim 1

A method of predicting a motor response in a negotiator comprising:
(a) measuring with a magnetic resonance imaging device a concentration of glutamate and gamma aminobutyric acid (GABA) within a voxel of interest in a primary motor cortex of the negotiator;
(b) challenging the negotiator of step (a) with a simulation of a conflict;
(c) repeating step (a);
(d) processing the glutamate and GABA concentration of steps (a) and (c) as a ratio; and
(e) predicting the motor response of the negotiator from the ratio of step (d).

### Claim 2

A method of predicting a motor response in a negotiator comprising:
(a) measuring with a magnetic resonance imaging device a concentration of glutamate and gamma aminobutyric acid (GABA) within a voxel of interest in a supplementary motor cortex of the negotiator;
(b) challenging the negotiator of step (a) with a simulation of a conflict;
(c) repeating step (a);
(d) processing the glutamate and GABA concentration of steps (a) and (c) as a ratio; and
(e) predicting the motor response of the negotiator from the ratio of step (d).
